Healthcare - Sector
DARE is currently covered by 3 analysts
Dare Bioscience's activity chart (see below) currently has 13 price targets and 30 ratings on display. The stock rating distribution of DARE is 66.67% BUY and 33.33% HOLD.
Analysts' price targets on this stock were met 72.92% of the time, taking 925.38 days on average.
Highest price target for DARE is $2, Lowest price target is $2.
Most recent stock forecast was given by DOUGLAS TSAO from HCWAINWRIGHT on 02-Dec-2025. First documented stock forecast 17-Aug-2018.
Currently out of the existing stock ratings of DARE, 2 are a BUY (66.67%), 1 are a HOLD (33.33%).
Analyst name
Rating
Current price target
Potential Upside
Previous price target
Date of last PT
Price targets met ratio
Average potential upside
Average Days to Hit Target
Performance score
Buy Since 18-Dec-2020
$12
11 months 19 days ago
(02-Dec-2025)
1/6 (16.67%)
$9.16 (322.54%)
1042
Hold Since 04-Sep-2025
$8
1 years 2 months 17 days ago
(04-Sep-2025)
1/2 (50%)
$5.87 (275.59%)
2316
Buy Since 18-Aug-2025
$11
1 years 3 months 3 days ago
(18-Aug-2025)
1/2 (50%)
$8.89 (421.33%)
203
Buy Since 30-Nov-2022
$13
$5
2 years 3 months 5 days ago
(16-Aug-2024)
2/3 (66.67%)
$9.43 (264.15%)
149
Buy Since 13-Aug-2021
$2
$3
3 years 2 months 23 days ago
(30-Aug-2023)
4/4 (100%)
$-6.52 (-76.53%)
856
What is DARE (Dare Bioscience) average time for price targets to be met?
Which analyst most recently updated their price target on DARE (Dare Bioscience)?
Which analyst has the lowest performance score on DARE (Dare Bioscience) with a proven track record?
Which analyst has the most public recommendations on DARE (Dare Bioscience)?
Which analyst is the currently most bullish on DARE (Dare Bioscience)?
Which analyst is the currently most reserved on DARE (Dare Bioscience)?